Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationInt. J. Dermatol.. 2005, 44(5):378-83
AbstractAIM: The Nordic Quality of Life Study was undertaken to assess the relationship between psoriasis and the quality of life in Nordic countries. The intention was also to determine whether there was a relationship between drinking, smoking, and the use of psychotherapeutic agents on the one hand, and psoriasis severity and quality of life on the other. MATERIALS AND METHODS: A questionnaire was mailed to 11,300 members of the Nordic Psoriasis Associations. Additional psoriasis patients were recruited by dermatologists (387) or admitted to dermatologic wards (385). These patients also underwent a physical examination, and their Psoriasis Area and Severity Index (PASI) was determined. The questionnaire included the Psoriasis Disability Index (PDI), Psoriasis Life Stress Inventory (PLSI), and additional questions on disease severity, treatment, and psoriasis arthritis. It also included questions regarding lifestyle issues, such as smoking, alcohol use, and the use of tranquilizers, antidepressants, and sleeping medications. RESULTS: The response rate for members was 50.2%. Included in the evaluation were 6497 patients. Men drank significantly more beer and liquor than women. The number of beers per day had a weak correlation with the PDI. Wine consumption, however, showed a weak, but significant, negative correlation with both PDI and PLSI. Patients admitted to dermatologic wards smoked more cigarettes and drank less wine than the other two groups. Significant differences were found between countries with regard to total alcohol consumption and cigarette smoking. The number of cigarettes and the use of tranquilizers, sleeping medications, and antidepressants showed small, but significant, positive correlations with psoriasis quality of life measures. CONCLUSIONS: Cigarette smoking and the use of tranquilizers, sleeping medications, and antidepressants are statistically correlated with impaired psoriasis-related quality of life.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
- Authors: Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE
- Issue date: 1997 Nov
- Physical and psychologic measures are necessary to assess overall psoriasis severity.
- Authors: Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE
- Issue date: 2001 Jul
- Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
- Authors: Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D, Italian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group.
- Issue date: 2006 Feb
- Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
- Authors: Sampogna F, Tabolli S, Söderfeldt B, Axtelius B, Aparo U, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators.
- Issue date: 2006 May
- Psoriasis has a major secondary impact on the lives of family members and partners.
- Authors: Eghlileb AM, Davies EE, Finlay AY
- Issue date: 2007 Jun